, ,

Dr. Sanjay Gupta on CNN: “Ketamine offers lifeline for people with severe depression, suicidal thoughts”

In this post, a Wisconsin man who had been on the brink of suicide, told CNN’s Sanjay Gupta how Ketamine infusions stopped his suicidal thinking after traditional anti-depressants failed him. At our Boulder Ketamine Infusion Clinic, we see such dramatic, life-changing responses in our patients every week.

If you or a loved one are suffering with depression, suicidal thinking, PTSD, or severe anxiety, contact us now at Boulder Mind Care to turn your life around and “Love Your Life!”.

, ,

The Resurgence of Psychedelics in Medicine

There has been a flurry of articles in the media recently touting the successful use of psychedelics in medicine. Tim Ferriss, the New-York Times bestselling author, blogger, and angel investor, whose podcast has over 200 million downloads, recently interviewed Michael Pollan about his new book on the emerging science of psychedelics in what Ferriss dubbed “the most important podcast episode  I’ve put out in the last two years”.

Ferriss is so passionate about this topic that he has publicly committed to donating a million dollars of his own money to support the scientific study of psychedelic compounds.

Examples of the emerging successful use of these compounds in medicine include ketamine for depression, PTSD, anxiety, and chronic pain, MDMA for psychotherapy and PTSD, psilocybin for cluster headaches and terminal cancer patients, and Ibogaine for drug addiction.

Here in the front range of Northern Colorado, local journalist Reilly Capps recently published an interesting article on the topic as well.

Indeed, ketamine infusions are not voodoo medicine, not fringe science, rather they truly are a paradigm-shifting revolution.

,

Ketamine Infusions Provide Effective Relief for Severe Chronic Headache

Medical research is revealing more and more applications for ketamine, the old drug being used in new ways. Just as with Treatment Resistant Depression, where ketamine provides relief in 80% of patients, it is also often successful at relieving intractable headache pain. Indeed, the term “Treatment-Resistant Headache” could be used for the millions of women and men suffering from chronic, severe migraine headaches. Many of these patients spend years trying to find relief using a variety of medications and adjunctive therapies, often in vain.

Ketamine provides significant pain relief among patients with refractory headaches, as per study findings presented  by Eric Schwenk MD, at the annual meeting of The American Society of Anesthesiologists, held October 21-25, 2017 in Boston, Massachusetts.

Dr. Schwenk, associate professor and director of orthopedic anesthesia at Jefferson University Hospitals in Philadelphia, stated “We found that patients with these types of headaches who received infusions of ketamine experienced improved pain control during their infusions.” “The findings of this retrospective study are exciting as they point to a {breakthrough} for patients who have failed essentially all other options,” concluded Dr Schwenk.“

At Boulder Mind Care, we are achieving success using Ketamine infusions to provide relief for severe migraines, and other intractable types of head and facial pain. We are here to help you “Love your Life”, to no longer spend day after day, year after year, laying in bed at home in misery, unable to work, play, be a good parent or spouse, and generally enjoy life. Contact us today.

, ,

New Insight Into How Ketamine Works in Depression

Ketamine exerts an initial antidepressant effect by blocking the N-methyl-D-aspartate receptor (NMDAR), and the ketamine metabolite hydroxynorketamine (HNK) may extend the duration of the effect. The findings could lead to the development of safer alternatives.

more… (registration required)

,

Techies Are Using Ketamine to Fight Their Depression

Sean Spencer is a pretty successful entrepreneur in LA’s startup community but he also struggles with depression, so he uses ketamine to help with his lows.

 

,

Inside the Los Angeles Clinic That Uses Ketamine to Treat Depression

Depression is all too common, especially among people in the tech sector. That’s why denizens of Silicon Beach have been flocking to a local clinic that offers a radical alternative when standard treatments fall short.

more…

,

How Untreated Depression Contributes to the Opioid Epidemic

It can sometimes seem strange how so much of the country got hooked on opioids within just a few years. Deaths from prescription drugs like oxycodone, hydrocodone, and methadone have more than quadrupled since 1999, according to the CDC. But pain doesn’t seem to be the only culprit: About one-third of Americans have chronic pain, but not all of them take prescription painkillers for it. Of those who do take prescription opioids, not all become addicted.

more…

,

FDA Data Support Ketamine as Depression Therapy

An analysis of data from the FDA Adverse Events Reporting System (FAERS) supported previous findings that ketamine could be an effective treatment for depression, researchers found.

more…

,

Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications

Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis of eight million reports from the FDA Adverse Effect Reporting System. The results of the examination of population scale data revealed that patients who received ketamine had significantly lower frequency of reports of depression than patients who took any other combination of drugs for pain. The analysis also revealed that patients who took ketamine had significantly lower frequency of reports of pain and opioid induced side effects, implying ketamine’s potential to act as a beneficial adjunct agent in pain management pharmacotherapy. Further, the Inverse-Frequency Analysis methodology provides robust statistical support for the antidepressant action of other currently approved therapeutics including diclofenac and minocycline.

more…

,

Ketamine For Severe Depression: ‘How Do You Not Offer This Drug To People?’

Gerard Sanacora, a professor of psychiatry at Yale University, has treated hundreds of severely depressed patients with low doses of ketamine, an anesthetic and popular club drug that isn’t approved for depression.

more…